Chemokine and Co-stimulatory Molecule-modified Mesenchymal Stem Cells therapy(Shanghai East Hospital)

N/A

Report date: 2024/06/11 20:00:08

Base Information

Drug NameChemokine and Co-stimulatory Molecule-modified Mesenchymal Stem Cells therapy(Shanghai East Hospital)
Drug Alias NameCXCL Chemokine and TNF Superfamily Co-stimulatory Molecule-modified Mesenchymal Stem Cells therapy(Shanghai East Hospital)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Gene therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Oriental Hospital
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Oriental Hospital
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A